Health crisis ignored by EU governments for 6 years - millions suffer in silence

An open letter to Europe's political leaders, media and organisations

Health crisis ignored by EU governments for 6 years - millions suffer in silence

An open letter to Europe's political leaders, media and organizations

The report letter was sent to the following recipients in Europe:

Dear European Political Leaders,

Dear Members of the Media,

Dear Representatives of Esteemed Organizations,

This is nothing less than a crime against humanity. For six years, EU governments have quietly disregarded the 2018 European Parliament resolution concerning the bacterial infection Borrelia, which is believed to affect approximately 25% of the European population. This neglect has left millions across the continent suffering in silence—misdiagnosed, untreated, and abandoned by the healthcare systems that are supposed to protect them.

Recent discoveries regarding Borrelia and related infections reveal significant shortcomings in the current understanding and treatment of the disease.

1) We provide evidence of incompetence among doctors in some of the largest hospitals in European countries, along with clear data showing that the healthcare systems in these nations are more than 20 years behind modern standards.

2) Furthermore, we present real cases of patients who have been rendered disabled due to doctors neglecting their complaints, along with proof of their infections. These very individuals, now disabled, continue to be ignored and left untreated.

3) Additionally, we offer evidence of completely incorrect diagnoses and treatments of the infection.

4) Finally, we present our formal demands to the healthcare systems.

This hidden crisis is destroying lives, yet remains buried under medical negligence. The EU lacks an approved diagnostic method for Borrelia, leading to widespread misdiagnoses or outright dismissal of millions of patients. This has resulted in irreversible damage or even death. The absence of regulations in the EU allows doctors to play god, deciding who will live.

5) Here is what is being concealed and why this issue urgently demands attention:

— Despite the 2018 European Parliament resolution proposal on Borrelia infection, which calls for the immediate establishment of standardized protocols for diagnosis and treatment, governments have not responded, leading to the continued suffering of millions across the continent.

— Recent studies indicate that up to 25% of the European population may be infected with the disease, far exceeding the official reports published decades ago. The lack of accurate testing and widespread underreporting make this the largest health crisis of our time.

— Across Europe and the U.S., patients report that their Borrelia symptoms are dismissed as "stress" or "psychiatric issues," while the bacteria silently ravages their bodies. When left untreated, irreversible damage occurs, leaving individuals permanently disabled.

— There is evidence from research centers worldwide that completely reshapes the understanding of this infection, yet no government or healthcare system is willing to make this information publicly available.

— The most prevalent infection in the world is not included in routine prenatal screenings, unlike syphilis. Our reports provide scientific evidence of mother-to-child transmission of the disease. This omission exposes pregnant women and their unborn children to serious risks, leading to miscarriages, stillbirths, and long-term, irreversible developmental problems.

— Our reports present critical evidence showing that the current diagnostic tools and treatment protocols are dangerously flawed. While this information is publicly accessible, healthcare systems seem to deliberately ignore the scale of this crisis.

— Health authorities in Virginia and Maryland, USA, are legally required to inform their patients that negative Lyme disease tests do not rule out the presence of infection. The law explicitly states that these tests are unreliable.

— In Europe, the situation is quite the opposite — patients in critical condition with positive test results are often led to believe by doctors that they do not have the infection. This constitutes a serious breach of medical ethics and a crime. Doctors and the entire healthcare system are directly responsible for the ruined lives and ongoing suffering of these patients. During the time it took to prepare these reports and gather contacts, patients have already passed away.

References to the relevant laws: Maryland: LAWRENCE J. HOGAN, JR., Governor, (Senate Bill 926, https://mgaleg.maryland.gov/2016RS/chapters_noln/Ch_450_sb0926T.pdf

Virginia: 2021 Code of Virginia Title 32.1 - Health, Chapter 5 - Regulation of Medical Care Facilities and Services, § 32.1-137.06. Lyme disease test result information (https://law.justia.com/codes/virginia/2021/title-32-1/chapter-5/section-32-1-137-06/)

At LymeCare Alliance, we are fighting to bring this injustice to light and ensure that Borrelia patients receive the correct diagnosis, care, and treatment they deserve. We cannot achieve this alone — we need the support of the media to expose this systemic neglect and save lives by making the truth accessible to the public.

Your influential voice can serve as a catalyst for real change, helping to protect millions of people by reporting the facts and giving them a chance to understand what is happening to their health.

The suffering Europeans highlighted in our reports are slowly dying, with no one to protect them or to voice the challenges they face. Only you can reveal the truth. Meanwhile, hundreds of thousands more across the country rely on you to spread accurate scientific information and offer the possibility of a more precise diagnosis.

6) We are providing a separate report with cases of patients from European countries, along with a file containing their contact information and medical documentation. All of these patients are ready to confirm the slow execution they have suffered at the hands of their country’s healthcare system. Sadly, others have already passed away.

Bring this urgent story into the spotlight and onto the political agenda.

7) We also share critically important information on how more accurate testing can be conducted.

It is of paramount importance for the entire society to thoroughly review all the attached reports.

REPORT ON THE PANDEMIC

Evidence of the Hidden Pandemic

Studies indicate that millions of people worldwide are at risk of contracting Borrelia infections. While the true scope of this hidden pandemic has been recognized, it remains largely underreported. Below is an excerpt from a scientific publication, now six years old, which outlines the scale of this growing crisis:

“Estimates for the world for 2018 are: incidence 12.3 million per year; prevalence 62.1 million; and total infection burden 262.0 million.”

These are the data from 2018. Let’s move on to more recent findings:

The top three regions with the highest seroprevalence were Central Europe (to 28.6%), Eastern Asia (to 28.3%), and Western Europe (to 18.0%).

Statistically, this means that if you're in a room with four people, there's a good chance one of them has Borrelia.

Sources:

An urgent motion for a resolution on Lyme disease has been submitted to the European Parliament, yet governments and the EU remain silent

In 2018, a proposal for a resolution on Lyme disease (borreliosis) was submitted to the European Parliament, drawing attention to critical gaps in the diagnosis, treatment, and awareness of this increasingly widespread disease. Despite this proposal, governments across Europe have largely remained silent, taking little significant action to address the issue.

The resolution highlights key concerns, particularly the lack of a European consensus on the treatment, diagnosis, and screening of Lyme disease, with national practices varying significantly (Point E). This lack of standardization has resulted in inconsistent healthcare responses, leaving many patients facing delayed diagnoses and inadequate treatment. The proposal also emphasizes that the true burden of Lyme disease in the EU remains unknown due to inconsistent statistical data, varying case definitions, and differing laboratory methods (Point J).

Despite these pressing concerns, no steps have been taken to establish a unified European approach, leaving many patients without the care and support they need.

Reference: MOTION FOR A RESOLUTION on Lyme disease (Borreliosis)

Lyme disease can be transmitted from pregnant women to their babies

One of the lesser-known yet deeply concerning aspects of Lyme disease is its ability to be passed from pregnant women to their unborn children. This phenomenon, known as congenital Lyme borreliosis, occurs when the Borrelia bacteria cross the placental barrier, infecting the fetus during pregnancy.

Research shows that untreated Lyme disease in pregnant women can lead to serious complications for the baby, including miscarriage, stillbirth, premature birth, and developmental issues after birth. The bacteria can infect the brain, heart, and other vital organs of the fetus, potentially causing long-term health problems.

Even more concerning is that many pregnant women are unaware they have Lyme disease, as its symptoms can be subtle or misdiagnosed. As a result, many babies are born with the infection without the mother receiving the appropriate treatment.

Sources:

Although Lyme disease is the most common vector-borne infection worldwide, pregnant women and those undergoing in vitro fertilization are not routinely screened for it. This stands in sharp contrast to syphilis, which is a standard prenatal screening test. Both Lyme disease and syphilis are caused by spirochete bacteria and can have severe consequences if transmitted to the fetus, including miscarriage, stillbirth, or developmental issues.

Given the potential risks, there is an urgent need to incorporate Lyme disease screening into prenatal care to ensure early detection and treatment, similar to the approach taken with syphilis.

Possible Sexual Transmission of Lyme Disease

Lyme disease, caused by the Borrelia bacterium, belongs to the same family as the well-known sexually transmitted infection, syphilis. Under a microscope, the two bacteria appear almost indistinguishable.

In a groundbreaking revelation, researchers are now challenging the long-held belief that Lyme disease is transmitted solely through tick bites. New evidence suggests that Borrelia may also be spread through sexual contact.

While Lyme disease has traditionally been associated with tick bites, emerging studies point to the possibility of human-to-human transmission. According to a recent study, both animal and human research have uncovered alarming evidence that Borrelia bacteria can be transmitted during intimate encounters, much like syphilis.

In one experiment, Borrelia was found in the genital secretions of individuals infected with Lyme disease, including heterosexual couples who engaged in unprotected sex.

The implications of this discovery are staggering, suggesting a much broader route of transmission than previously thought, potentially affecting millions more people worldwide.

Sources:

Doctors Are Unaware of the True Symptoms of Lyme Disease in Europe

One of the most glaring issues in the global Lyme disease crisis is the profound misunderstanding of its symptoms—even among trained healthcare professionals. Most doctors are familiar only with the "classic" symptoms of Lyme: rash, joint pain, and flu-like illness following a tick bite. However, the reality is far more complex and dangerous.

There are over 20 known species of Borrelia that can infect humans, each causing a wide range of symptoms. These include Borrelia burgdorferi (the main cause of Lyme disease in North America), Borrelia afzelii and Borrelia garinii (most common in Europe and Asia), among others. Each species can trigger its own unique set of symptoms, many of which extend far beyond the typical signs of Lyme that doctors are trained to recognize.

For instance, while some species primarily affect the skin and joints, others may target the nervous system or heart, leading to neurological symptoms, cognitive decline, or heart block. Even experienced doctors are often unaware of this variety, resulting in frequent failures in diagnosis and treatment.

In fact, many physicians in Europe are unaware of how many different Borrelia species cause Lyme disease or the broad spectrum of symptoms each species can induce. Even more concerning is that most healthcare professionals don't realize that it is not uncommon for a patient to carry multiple species of Borrelia at once.

How is it possible for so many people to suffer from a single bacterial infection without adequate diagnosis or treatment?

Borrelia is often referred to as "The Great Imitator" because its symptoms are vague, diverse, and can mimic countless other conditions—chronic fatigue syndrome, fibromyalgia, multiple sclerosis, rheumatoid arthritis, and even psychiatric disorders such as depression or anxiety. The complexity of the infection has created the perfect storm for misdiagnoses.

Lyme disease symptoms can affect multiple systems in the body, from the nervous system to the joints and heart, making it difficult for doctors to pinpoint the underlying cause. Its ability to mimic other illnesses often leads healthcare professionals to misinterpret the signs, resulting in patients being treated for the wrong conditions. Additionally, the variability of symptoms among different Borrelia species and the potential for co-infections further complicate diagnosis. This combination of factors explains why so many people remain undiagnosed or inadequately treated despite suffering from the same bacterial infection.

Patients with diseases like multiple sclerosis (MS) and fatal conditions such as ALS have had undiagnosed Lyme disease for many years

Multiple sclerosis (MS) is a severe, debilitating disease that primarily affects young adults. Despite advances in symptom management and disease-modifying therapies, there is no cure. The prevalence of MS coincides with the spread of the Lyme disease pathogen Borrelia burgdorferi, which is transmitted by ixodid ticks. The seasonal patterns of MS cases align with those of Lyme disease, suggesting a potential connection.

Some patients diagnosed with MS or even more fatal conditions like ALS (amyotrophic lateral sclerosis) have been found to suffer from undiagnosed Lyme disease for years. Given the overlapping symptoms—such as neurological issues, muscle weakness, and fatigue—many of these patients were misdiagnosed and missed out on timely treatment for Lyme disease. This further complicates the medical community’s understanding of both conditions and highlights the need for greater awareness and more comprehensive diagnostic practices when dealing with patients who exhibit overlapping symptoms.

Reference: Chronic Lyme borreliosis at the root of multiple sclerosis – is a cure with antibiotics attainable?

Another report discusses a 45-year-old woman diagnosed with multiple sclerosis (MS), who was also found to have positive serology for Lyme disease.

Reference: MULTIPLE SCLEROSIS AND POSITIVE LYME SEROLOGY

A study in Suffolk County, New York, found that 9 out of 19 patients diagnosed with amyotrophic lateral sclerosis (ALS) had serologic evidence of exposure to Borrelia burgdorferi (Lyme disease), compared to 4 out of 38 controls. Most seropositive patients were male, and some showed improvement with antibiotic treatment, while others did not. This suggests a potential association between ALS and Borrelia infection, particularly in hyperendemic Lyme areas, though none of the ALS patients had typical Lyme disease symptoms.

Reference: "Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease"

A case study reported significant recovery in a patient initially believed to have ALS after being treated with antibiotics for Lyme and Babesia infections. This raises the alarming possibility that some ALS diagnoses could be mistaken, with the true cause being Lyme disease. The connection between ALS and Lyme exposure has shown a statistically significant link, particularly in areas where Lyme is prevalent, sparking urgent calls for further investigation.

Reference: "Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy"

Even Scarier: Lyme Disease Tests Don’t Work, and Doctors Don’t Know It

There are over 20 known species of Borrelia that can cause Lyme disease, each presenting unique challenges for testing. Most tests are designed to detect antibodies to Borrelia burgdorferi, the most common strain in North America. However, infections caused by other strains, particularly in Europe and Asia, may go undetected, leading to false negatives.

Borrelia bacteria are also known for their ability to hide within tissues, making it difficult for the immune system to detect them. As a result, patients may not produce enough antibodies for a test to detect, even though the bacteria remain active in their bodies. Once the bacteria infiltrate the brain, nervous system, tendons, or eyes, tests may continually return negative results, despite an active infection.

Although the Western blot test is considered the gold standard, it has limitations. In many countries, it only measures a small number of protein bands—often just 5-7—compared to over 15 in others. According to CDC guidelines, five positive bands are required for an official diagnosis, leaving many patients undiagnosed. This leaves infections untreated, leading to disability or even death for many sufferers.

The CDC’s outdated guidelines for Lyme disease testing, which require patients to show five positive bands on a Western blot test for a formal diagnosis, are part of the problem. Millions of individuals who show only one or two bands remain undiagnosed and untreated, leading to serious long-term health consequences.

False-negative results from ELISA tests are a major barrier to identifying Lyme disease. These tests, due to their low sensitivity, often fail to detect the infection, delaying treatment. Physicians should stop relying solely on ELISA tests for diagnosis, as this method frequently misses active infections.

A recent study revealed significant issues with current diagnostic tests for Lyme disease, particularly with the widely used ELISA test. Researchers compared eight different ELISA systems and five immunoblots, uncovering major discrepancies in detecting anti-Borrelia antibodies. They found that many patients suspected of having Lyme disease receive false-negative results, leaving them undiagnosed and untreated.

The study, which tested 89 patient samples, found that the percentage of positive ELISA results varied widely, from 34% to 61%. This inconsistency highlights a serious problem in the diagnostic process, as many patients with active infections are not being accurately identified. Some tests even produced negative results in patients who were later confirmed to have Lyme disease through other methods. ("Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots", C. W. Ang, D. W. Notermans, M. Hommes, A. M. Simoons-Smit, and T. Herremans, 2011)

Borrelia Biofilms: Another Overlooked Topic Among Mainstream Doctors

One of the lesser-known and poorly understood aspects of Lyme disease is the formation of Borrelia biofilms, a topic unfamiliar to many healthcare professionals. Biofilms are protective layers formed by bacteria, allowing them to survive in hostile environments, evade the immune system, and resist antibiotic treatments. In the case of Lyme disease, Borrelia can form these biofilms within the human body, making the infection much more persistent and harder to treat.

Biofilms are up to 1000 times more resistant to antibiotics.

Reference: Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance

Pre-Test Preparation for Lyme Disease: Breaking Down Biofilms

Before undergoing Lyme disease testing, patients should prepare by stimulating the immune system and breaking down Borrelia biofilms over the course of one month. This preparation process helps improve the accuracy of the tests, as it increases the likelihood of detecting the bacteria in the system. By targeting the biofilms and boosting immune activity, the chances of receiving more precise results are significantly enhanced.

For a detailed guide on how to prepare for Lyme disease testing, including the importance of breaking down biofilms and stimulating the immune system, be sure to read the article "Preparing for Lyme Disease (Borrelia) Testing." This information can greatly improve your chances of getting accurate test results.

The Failure of Doctors to Recognize Borrelia is Crippling and Killing People

The lack of knowledge about Lyme disease among doctors can have devastating consequences for patients. Misdiagnosis and incompetence can turn once active and healthy people into disabled individuals. Most doctors have no real understanding of the disease’s symptoms. They may have read outdated textbooks containing incorrect information, and many have likely never read a single text on the subject. As a result, these oversights are leaving people to suffer lifelong illness or even death.

Treatment: It’s Not What’s in the Textbooks, and Every Doctor Should Know This

Patients who are fortunate enough to receive an official Lyme disease diagnosis are often given a single course of antibiotics and then sent on their way, expected to resume their lives. However, many people with long-term infections and severe symptoms experience little to no improvement after this treatment. There are a handful of patients who receive more comprehensive care, undergoing multiple courses of antibiotic therapy throughout the year—sometimes for years. These individuals can attest to the true pace and effectiveness of treatment. A single course of antibiotics is unlikely to cure anyone suffering from chronic Lyme disease. While it may be sufficient for treating a simple urinary infection, Lyme disease requires prolonged and carefully managed therapy. The realities of treatment and its necessary duration are not secrets—they must be understood by all healthcare professionals.

A study by Preac-Mursic et al. highlights the persistence of Borrelia burgdorferi in patients even after antibiotic treatment. The researchers found that despite treatment, the bacteria could still be cultured from patients' tissues, and some individuals continued to experience clinical or subclinical disease without detectable antibody levels. This suggests that antibiotic therapy can sometimes suppress the immune response, making traditional tests unreliable for detecting ongoing infections. The study concludes that both early and chronic Lyme disease, with persistent Borrelia after treatment, cannot be ruled out based on negative antibody tests. ("Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis")

A study by Hodzic et al. investigated the effectiveness of antibiotic treatment in a mouse model of Lyme disease. Mice infected with Borrelia burgdorferi were treated with ceftriaxone during both early and chronic stages of infection. While the antibiotic treatment rendered the mice consistently culture-negative, some tissues remained PCR-positive, and spirochetes were found in collagen-rich tissues. Additionally, ticks that fed on treated mice were able to acquire and transmit the spirochetes to uninfected mice, indicating that non-dividing but infectious spirochetes persisted. This was especially pronounced in mice treated during the chronic stage of infection. ("Persistence of Borrelia burgdorferi following Antibiotic Treatment in Mice")

It simply means that when you’re given antibiotics and test negative afterward, it only indicates one thing—the blood test is negative, but the bacteria remain deeply embedded in your collagen tissues, still intact.

And Now the Reality Becomes Even More Brutal

A study led by Eva Sapi and colleagues investigates whether Borrelia, the bacterium responsible for Lyme disease, can persist in the body even after long-term antibiotic treatment. The study analyzed tissues from a 53-year-old Lyme disease patient who had undergone 16 years of extensive antibiotic therapy. Despite treatment, the researchers found Borrelia antigens, DNA, and biofilm clusters in the patient's organs, including the brain, heart, kidney, and liver. These findings suggest that Borrelia can persist in both its spirochete form and antibiotic-resistant biofilm form, causing chronic infection. The presence of inflammatory markers next to these biofilms indicates that these persistent bacteria may continue to trigger inflammation, leading to long-term health problems. ("The Long-Term Persistence of Borrelia burgdorferi Antigens and DNA in the Tissues of a Patient with Lyme Disease")

This study provides strong evidence that Borrelia burgdorferi can survive in the human body despite aggressive antibiotic treatment, challenging the current understanding of Lyme disease treatment protocols.

This has been proven by many other microbiologists and scientists, including Monica Embers:

Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection

Doctors will never admit this. Many are not even aware of these studies. In fact, it’s possible that some have never read any research beyond the textbooks they studied decades ago.

An Even More Frightening Truth

There are over 350 diseases known to be associated with Lyme borreliosis. Below is a list of just a few of them. You can download and review the full list, along with a collection of reports.

Amyotrophic Lateral Sclerosis (ALS - Lou Gehrig's Disease)
Alzheimer’s Disease
Acute ischaemic pontine stroke
Severe cardiac diseases (Acute coronary syndrome, Cardiomyopathy, Cardiac Disease)
Severe neurological diseases (Acute myelitis, Transverse myelitis, Guillain-Barré Syndrome, Multiple Sclerosis, Progressive supranuclear paralysis)
Stroke (Progressive stroke, Subarachnoid hemorrhage)
Respiratory failure
Septic arthritis
Neonatal respiratory distress
Sudden infant death syndrome (SIDS)
Chronic Fatigue Syndrome
Fibromyalgia
Meningitis
Cerebral atrophy
Scleroderma
Rheumatoid Arthritis
Polymyalgia rheumatica
Systemic vasculitis (Wegener's granulomatosis, Vasculitis)
Dementia (Presenile dementia, Reversible dementia)

There are over 320 more confirmed conditions listed in the file.

A Crime Against Humanity

When someone commits murder, it is a felony. Manslaughter due to negligence is also punishable by law, leading to indictments and imprisonment. Yet, the healthcare system and doctors are shielded by their status. However, any form of negligence, incompetence, or denial in providing care is nothing short of a crime against humanity.

DESCRIPTION OF PATIENT CLINICAL CASES

Clinical case: XXXXXX XXXXXX

Country: Germany, *********@***********.com

Background:

The patient, Ms. XXXXXX XXXXXX, began experiencing initial symptoms of Lyme disease in 2007, including joint pain and neurological issues. She was initially treated with doxycycline, which provided temporary relief. In 2008, she developed eye symptoms, which were not addressed by German healthcare providers. Over the following years, she faced an increase in joint and spinal pain. Numerous diagnoses were considered, including joint overload and psychosomatic disorders, the latter of which was dismissed by psychiatric evaluation. Lyme disease was tested multiple times using only the basic ELISA method, which consistently returned negative results.

In 2016, after experiencing a stiff neck and involuntary thumb curling, Ms. XXXXXX consulted an infectious disease specialist in the United States. Clinical evaluation suggested neuroborreliosis, though limitations in U.S. tests for European Borrelia species made confirmation challenging. A six-week course of ceftriaxone led to temporary improvement, but symptoms recurred three months after treatment. In 2019, advanced testing was conducted at a specialized laboratory in Berlin, revealing borderline results on VLsE and positive IgG and IgM on a line blot, confirming persistent infection with Borrelia afzelii (strong positive).

Despite this positive diagnosis, a prominent Berlin clinic refused treatment, citing that the diagnostic tests were not conducted internally. Subsequently, Ms. XXXXXX consulted a Lyme disease specialist who initiated various antibiotic treatments, offering partial symptomatic relief.

Current Status:

Currently, Ms. XXXXXX manages a diminished quality of life with ongoing, recurrent symptoms. The refusal of treatment by local facilities, despite confirmatory test results, has left her reliant on limited options and private specialist care. Her case highlights significant barriers within the German healthcare system regarding Lyme disease diagnosis and treatment, where advanced diagnostic results from external labs are often disregarded.

Clinical case: XXXXXX XXXXXX

Country: UK, *********@**********.com

Background:

XXXXXX XXXXXX, a male patient from the UK, has been struggling with progressively worsening symptoms over the past five years. His condition initially began with general discomfort but has since escalated into a complex array of debilitating symptoms, including muscle weakness, generalized ligament laxity, dizziness, peripheral neuropathy, pain in his Achilles heel, and blurry vision. Despite his worsening condition, XXXXXX has not received appropriate medical treatment in the UK due to the limitations of standard diagnostic methods and the refusal of local doctors to acknowledge his positive results from advanced testing abroad.

XXXXXX's case represents a tragic example of how the limitations of conventional diagnostic methods and lack of awareness around tick-borne infections in the UK can lead to a patient's progressive deterioration. His experience highlights the growing concern around patients suffering from chronic Lyme disease and related infections, who are often left untreated due to negative results from standard tests like ELISA and skepticism regarding the presence of certain pathogens in the UK.

Clinical case: XXXXXX XXXXXX

Country: Bulgaria, *********@*********.com +359*********

Background:

The patient XXXXXX XXXXXX is experiencing a serious deterioration in her health, characterized by general fatigue and neurological symptoms. Due to her progressive illness, she is no longer able to care for her child. For a more accurate diagnosis, he sends blood samples abroad for analysis using the ELISpot method, which shows positive results for Borrelia infection (causing Lyme disease).

The patient was hospitalized in one of the leading hospitals in Bulgaria, where a test was carried out using the standard cheap ELISA method for the country, which was proven to be wrong compared to other modern methods. The results of this test come back negative. Two days later, without taking any additional diagnostic or therapeutic measures, the patient was discharged from the hospital with a refusal of further treatment.

Current status:

Currently, the patient is in a serious and helpless condition, not receiving the necessary attention and care from the medical specialists. Despite the positive results of the tests for Lyme disease carried out abroad, the treatment in Bulgaria was refused due to the negative result of the ELISA test. The patient's condition remains critical, with no available options for effective therapy in the country.

Clinical Case: XXXXXX XXXXXX

Country: Bulgaria, ***********@**********.com +359*********

Background:

In 2019, following a tick bite, XXXXXX XXXXXX began to experience neurological symptoms of a mixed nature. He consulted several specialists, starting with his general practitioner, who mockingly suggested that "the lack of alcohol consumption is causing the symptoms." From that point on, the patient personally financed regular and costly medical examinations and tests. A neurologist recommended testing for Lyme disease using the ELISA method, but the result was negative.

After spending approximately BGN 40,000 on various medical procedures over several years, the patient is now unable to move independently, relying entirely on his loved ones for basic care, such as feeding and bathing. He sought advice from a prominent professor at Sofiamed Hospital, who suspected neuroborreliosis and recommended additional tests, including those conducted at the National Center for Infectious and Parasitic Diseases (NCIPD) using the ELISA and Immunoblot methods, as well as the LTT method abroad. All test results returned negative, leading the professor to decline further treatment, citing the negative outcomes.

The test results from NCIPD clearly show that the tests conducted were for the American strain *Borrelia burgdorferi*, one of the rarest strains in Europe. The so-called "reference laboratory" in Bulgaria does not disclose the manufacturer of its tests or the exact nature of the analyses. Bulgarian citizens remain unaware of the specifics of the tests they undergo. Furthermore, NCIPD does not publicly disclose how the funds from sponsorships or the revenues from disabled citizens are allocated.

The tests conducted at NCIPD—which doctors consider "reference tests for Bulgaria"—continued to yield negative results. The patient was promised that he would be included the very next day in a "new special program at NCIPD" for Lyme disease diagnostics, but this never materialized. In desperation, the patient sent an email to the National Health Insurance Fund (NHIF) requesting guidance on how to receive an official diagnosis, but no response was ever received.

The patient’s condition further deteriorated as he was given a suspected diagnosis of the fatal neurological disease ALS, and was admitted to Aleksandrovska Hospital, one of Bulgaria’s leading neurology centers. However, the diagnosis was never confirmed. In the patient's presence, a doctor commented to another physician that his condition was psychiatric in nature. Desperate for answers, the patient sent blood samples abroad for testing, where an Ehrlichia infection was detected—a disease little known in Bulgaria and for which no tests are available. This infection is recognized by global health authorities as a co-infection of Borrelia (Lyme disease). Antibiotic therapy, initiated based on these foreign test results, provided some relief of symptoms. The patient also learned about the important step of stimulating the immune system prior to testing, in addition to the supportive effect of antibiotics.

New Lyme disease tests, conducted both abroad using the LTT method and in Bulgaria using the Western Blot (a variant of the Immunoblot), returned positive results. This time, the test from a private laboratory in Sofia clearly included the European strains of Borrelia. However, the largest hospitals in Bulgaria continued to refuse treatment. The same professor who had initially suspected neuroborreliosis reluctantly agreed to admit the patient to the hospital "out of pity." The patient was discharged with a recommendation to undergo further testing at NCIPD, leaving him devastated and feeling completely hopeless.

Current Prognosis and Condition:
The patient is now permanently disabled due to delayed diagnoses, unable to care for himself after years of medical errors. His condition is critical, bedridden, and entirely dependent on the support of his family, the result of prolonged misdiagnosis and inadequate treatment.

Clinical Case: XXXXXX XXXXXX

Country: Croatia, *************@**********.com

Background:
For over a year, XXXXXX XXXXXX has been seeking medical assistance due to progressively worsening health conditions, which have left her unable to fulfill her work responsibilities. She consulted a range of specialists, including infectious disease doctors, cardiologists, neurologists, and radiologists, and underwent numerous medical examinations. Despite these efforts, no doctor in Croatia has been able to diagnose her condition. Test results consistently suggest that she is healthy, yet her symptoms persist, severely impacting her quality of life—making even simple tasks like walking to her garden a challenge.

In Europe, chronic Lyme disease is not officially recognized, and doctors have dismissed her serology tests, reassuring her that she is not ill. Despite her declining health, no formal diagnosis has been provided.

At a recent visit to a neurologist, after expressing her worsening symptoms and the lack of previous prophylactic treatment, she was finally prescribed Doxycycline (100 mg twice daily for 10 days), marking the first attempt to address her condition.

Diagnosis and Treatment:
XXXXXX has also sought assistance abroad due to the lack of recognition for chronic Lyme disease in Croatia. She has arranged a consultation with an ILADS-certified doctor in Austria.

Though no doctor in Croatia has provided an official diagnosis, XXXXXX has received a positive test result for Lyme disease using the EFLA method. Furthermore, a Western Blot test also confirmed the presence of Lyme infection. Unfortunately, these results have been overlooked by local healthcare professionals, who have yet to recognize the severity of her illness.

Current Condition:
XXXXXX XXXXXX continues to struggle with her health, and her condition has not improved despite consulting multiple specialists. She remains unable to perform her job and is still without an official diagnosis in Croatia. She hopes that her upcoming consultation in Austria will yield a formal diagnosis, which she can use to advocate for treatment back in her home country.

Conclusion:
XXXXXX XXXXXX's case highlights the challenges faced by patients with chronic Lyme disease in Croatia, where the disease is not officially recognized. Despite positive test results, including those from the EFLA and Western Blot methods, her illness remains unacknowledged by Croatian doctors. XXXXXX’s experience underscores the limitations of local diagnostic and treatment protocols, forcing patients to seek care abroad at their own expense.

Clinical Case: XXXXXX XXXXXX

Country: Bulgaria, +359***********

Background:
XXXXXX XXXXXX has been suffering for years from progressively worsening health, which has led to an inability to live a normal life and care for his family. In Bulgaria, the patient underwent testing using the ELISA method, which is outdated and has low sensitivity, particularly for diagnosing Lyme disease in its later stages. The test returned a negative result and was conducted for a strain of Lyme disease more common in the U.S., not Europe, making the result even less relevant for this case.

As his condition did not improve and in search of a solution, the patient conducted his own research and discovered more accurate diagnostic options abroad. Tests performed using the Western Blot method and DFM (direct microscopic observation of spirochetes) revealed an infection with the European strain Borrelia afzelii.

Additional Infections:
Following the advice of a doctor outside the country, the patient underwent further testing for other infectious agents. An infection with Bartonella was also discovered, a chronic infection often unfamiliar to Bulgarian medical professionals. This co-infection of Lyme disease further complicated the clinical picture.

Treatment and Response:
The patient began antibiotic therapy, which triggered an immune response and increased antibody levels. During therapy, serum tests conducted in Bulgaria showed elevated antibody values, confirming the presence of an infection. This result supports modern scientific evidence that Borrelia can form biofilms, which make detection challenging through standard serum tests, especially when these tests are misinterpreted by specialists unfamiliar with recent research.

Conclusion:
XXXXXX XXXXXX is yet another example of a patient whose suffering has been prolonged due to outdated and improperly used diagnostic methods in Bulgaria. Despite the detection of infections with Borrelia afzelii and Bartonella through modern diagnostic methods, the patient continues to face challenges in receiving appropriate treatment in Bulgaria.

Clinical Case: XXXXXX XXXXXX

Country: Bulgaria, +359******** **********@***.bg

Background:
XXXXXX XXXXXX was bitten by a tick, after which his doctor advised him to wait without prescribing antibiotic therapy. Shortly after the bite, the patient began to experience neurological symptoms. Fortunately, despite the initial delay, the patient received an official diagnosis of Lyme disease in Bulgaria based on the tests conducted.

The patient underwent intravenous antibiotic therapy for one month but did not experience any improvement in his condition. Seeking more effective treatment, he turned to international therapy protocols and consulted doctors abroad. Over the next four months, he took six different antibiotics in various combinations, followed by injectable penicillin therapy and two additional oral antibiotics.

Diagnostic Methods and Results:
The patient underwent expensive microscopic testing abroad (DualDur method), which confirmed the presence of the bacteria that cause Lyme disease, even after all the previous treatments. However, the standard ELISA test, commonly used in Bulgaria for diagnosis, returned a negative result. This discrepancy between the results of different diagnostic methods highlights the limited sensitivity of the ELISA test, which is frequently used in Bulgaria to diagnose the disease.

Current Condition:
Despite all efforts, the patient has not achieved any improvement and describes himself as disabled. No Bulgarian doctor has shown interest in his condition or taken further steps for treatment or diagnosis. The patient continues to seek answers abroad, where chronic infection is confirmed through the most modern methods, but he receives no adequate support from Bulgarian medical professionals.

Conclusion:
XXXXXX XXXXXX is another patient in Bulgaria who, despite receiving a timely diagnosis and intensive therapy, has failed to see improvement. Outdated and limited diagnostic methods, such as the ELISA test, often fail to detect chronic and late-stage forms of Lyme disease. The lack of adequate response and interest from Bulgarian doctors has resulted in continued suffering and disability for the patient.

Clinical Case: XXXXXX XXXXXX

Country: Bosnia and Herzegovina, ************@********.com +387********

Background:
XXXXXX XXXXXX underwent testing for Lyme disease through the Elispot method, which indicated a "weak" infection. This test measures several types of Borrelia and the results referenced abbreviations for Borrelia afzelii (afz), Borrelia garinii (gar), and 'round bodies,' indicating persistent forms of the bacteria. These specific strains and bacterial forms remain largely unfamiliar to infectious disease specialists and laboratories in many European countries, highlighting a lack of awareness regarding advanced diagnostic methods.

The patient also received a negative test result from a local laboratory in Bosnia. However, the test method was not specified, although it is presumed to be ELISA, which is commonly used. This test likely targeted the American strain, Borrelia burgdorferi, which is not prevalent in Europe, making the negative result unsurprising. Additionally, the patient's immune system has been suppressed for many years, which is a significant factor contributing to the negative laboratory test results.

Diagnosis and Treatment:
After being abandoned by doctors in her own country, XXXXXX XXXXXX sought treatment abroad. She was fortunate to meet a professor in a neighboring country who was familiar with long-term treatment protocols for Lyme disease. Over the course of six months, the professor treated her comprehensively, addressing the multiple forms of the infection. Following this long-term therapy, the patient now describes her condition as nearly back to normal, with significant improvements in her health.

Current Condition:
XXXXXX XXXXXX is one of the few cases from the region who has seen near-complete recovery after receiving long-term treatment abroad. Her case stands in contrast to the usual medical approach in Europe, where many doctors refuse to acknowledge the chronic nature of Lyme disease or prescribe long-term treatment.

Conclusion:
XXXXXX XXXXXX's recovery further reinforces the findings of recent research that support long-term treatment for chronic Lyme disease, a practice commonly followed by Lyme specialists in the United States. While some doctors in Europe adopt this approach, they are often pressured or dismissed by governments. This case highlights the growing hidden pandemic of Lyme disease in Europe, which continues to disable millions, with many patients either undiagnosed or misdiagnosed. XXXXXX’s success story is a rare exception in a continent where many patients continue to suffer without proper treatment, and some even die without receiving a diagnosis.

Clinical Case: XXXXXX XXXXXX

Country: Bulgaria

Background:
XXXXXX XXXXXX began to experience progressively worsening health, which deteriorated to the point where she was admitted for treatment and diagnostics at almost all major hospitals in Bulgaria. Initially, doctors suspected cancer or severe systemic autoimmune diseases, performing multiple biopsies from various body tissues. Despite all efforts, the patient did not receive a definitive diagnosis and continued to suffer from unclear symptoms.

In search of answers, the patient sent blood samples abroad for Lyme disease diagnostics using the ELISpot method, which returned a negative result. However, as her symptoms continued to worsen, she decided to repeat the tests, again abroad. This time, the results from Western Blot and direct microscopy (DFM method) indicated the presence of antibodies for Lyme disease (specifically the European strain Borrelia garinii) and live spirochetes (spiral bacteria) were observed.

Diagnostic Challenges:
Despite the evidence from foreign laboratories confirming a Lyme disease infection, doctors in Bulgaria continued to doubt the diagnosis, instead hypothesizing the presence of oncological or autoimmune diseases. The patient decided to seek treatment at an expensive hospital in Turkey, where further tests were conducted, but once again, she was discharged without a diagnosis.

Current Condition:
At present, the patient is in an extremely critical condition, without a clear official diagnosis or effective treatment. Despite the positive results for Lyme disease from foreign tests, Bulgarian doctors do not recognize or accept the diagnosis, continuing to focus on other potential diseases, including cancer and autoimmune disorders, which they have yet to confirm.

Conclusion:
XXXXXX XXXXXX is yet another example of a patient whose condition remains unresolved due to limitations in diagnostics in Bulgaria and the lack of recognition of results from more modern and sensitive methods used abroad. Despite clear evidence of Lyme disease, she remains undiagnosed and untreated, leading to the progressive deterioration of her health.

Clinical Case: XXXXXX XXXXXX

Country: Bulgaria, +359**********

Background:
XXXXXX XXXXXX has been suffering from progressively worsening health for over three years. During this period, he has consulted neurologists in Plovdiv and Sofia in an attempt to obtain an accurate diagnosis and appropriate treatment. Initially, the patient experienced difficulty in muscle control, with his nervous system not functioning properly. Over time, his symptoms worsened, including speech impairment and a gradual loss of mobility, forcing him to rely on mobility aids. Later, he also developed weakness in his arms.

Similar to other patients, he was initially suspected of having a fatal disease—amyotrophic lateral sclerosis (ALS). However, after undergoing further testing abroad, this diagnosis was definitively ruled out.

Diagnostic Methods and Results:
In his search for answers, the patient sent blood samples abroad for analysis. Tests using the Western Blot method indicated the presence of specific proteins associated with Lyme disease. Additionally, direct microscopic observation through the DFM method confirmed the presence of spirochetes, characteristic of a Borrelia infection (the causative agent of Lyme disease).

Current Condition:
At present, the patient uses a walker and two canes due to severe muscle control issues and limited mobility. Despite the confirmed diagnosis of Lyme disease through more reliable and modern methods abroad, the patient has yet to receive adequate attention or treatment in Bulgaria.

Conclusion:
XXXXXX XXXXXX’s case is an example of a patient who endured a long and painful journey to obtain a diagnosis in Bulgaria but has not received adequate treatment due to the lack of modern diagnostic methods and understanding of advanced-stage Lyme disease. Despite the definitive rejection of ALS as a diagnosis abroad and the confirmation of Lyme disease infection, no treatment or support has been provided in Bulgaria.

Clinical Case: XXXXXX XXXXXX

Country: Bulgaria, **********@********.com

Background:
XXXXXX XXXXXX’s symptoms began two years ago, prompting her to visit numerous doctors in Bulgaria. Despite spending several thousand leva on various medical consultations and tests, none of the specialists could identify the root cause of her condition. This reflects a common problem with diagnosis and treatment in the country.

In 2023, the patient received a negative result from a standard Lyme disease test conducted in Bulgaria. However, due to the presence of clear specific proteins in the test results, she decided to begin antibiotic therapy, funding it herself and benefiting from treatment options available abroad.

Diagnosis and Treatment:
In January 2024, XXXXXX XXXXXX received a positive test result from a foreign laboratory, which "officially" confirmed a Lyme disease infection. This is yet another validation of the numerous scientific studies on the subject, which unfortunately remain unfamiliar to most doctors in Bulgaria. Due to her poor experience with Bulgarian doctors and the low standard of diagnostics in the country, the patient realized she could not rely on local healthcare for adequate treatment. She continued therapy based on personal research and consultations with international specialists.

Current Condition:
Today, XXXXXX XXXXXX is one of the few Lyme disease patients in Bulgaria who has shown significant improvement following treatment, which, however, was not provided by Bulgarian doctors. Thanks to timely antibiotic therapy and her initiative to seek help abroad, her condition has stabilized.

Conclusion:
XXXXXX XXXXXX's case highlights the shortcomings in Bulgaria’s healthcare system, particularly in the diagnosis and treatment of Lyme disease. The patient achieved improvement through timely and effective treatment, which she personally financed and received through foreign resources, remaining critical of the capabilities of Bulgarian doctors.

Clinical Case: XXXXXX XXXXXX

Country: Czech Republic, ********@********.com Phone: 777********

Background:
XXXXXX XXXXXX has faced repeated refusals from doctors in the Czech Republic to provide appropriate treatment, despite having both a positive Western Blot test and a positive ELISA test for Lyme disease. His medical reports indicate that although diagnostic evidence of Lyme disease is clear, several healthcare providers have dismissed his condition, claiming that it does not qualify as Lyme disease.

Diagnosis and Treatment:
Frustrated by the lack of support from public healthcare, XXXXXX XXXXXX sought treatment from a private doctor in Prague. During this private consultation, additional infections beyond Lyme disease were identified, highlighting the complexity of his condition. Despite the ongoing refusal of public healthcare providers to treat his Lyme disease, the private doctor has recognized the need for comprehensive treatment, which includes addressing multiple infections.

Current Condition:
At present, XXXXXX XXXXXX continues his treatment with the private physician in Prague.

Conclusion:
XXXXXX XXXXXX’s case demonstrates the challenges patients in the Czech Republic face when dealing with Lyme disease, particularly in receiving recognition and treatment from the public healthcare system. Despite positive test results from recognized diagnostic methods, his condition was dismissed by multiple doctors, forcing him to seek care from a private practitioner. This case highlights the need for improved diagnostic protocols and a more comprehensive understanding of Lyme disease within the country’s healthcare system.

Clinical Case: XXXXXX XXXXXX

Country: Republic of Moldova

Background:
XXXXXX XXXXXX, an 8-year-old boy from the Republic of Moldova, was bitten by a tick in May 2023. A few days after the bite, his mother, XXXXXX XXXXXX, noticed what appeared to be a small scab on his leg, which initially resembled a fine black thread.

Approximately six weeks after the tick bite, his mother noticed a faint red spot on his leg. The mother contacted their family doctor via Viber, who dismissed the red spot as an allergy. However, after consulting their pediatrician, who asked if XXXXXX had been bitten by a tick, the connection to Lyme disease was made. The red spot was identified as erythema migrans, a classic sign of Lyme disease.

Diagnosis and Treatment:
The next day, Filimon underwent an ELISA test, which came back positive for Borrelia. He was promptly taken to the Infectious Diseases Hospital in XXXXXX, where Dr. XXXXXX XXXXXX prescribed the following treatment (for his weight of 25 kg):

Ceftriaxone 750 mg intramuscularly, twice daily, for 5 days
Followed by Cefuroxime 200 mg once daily (although the dosage should have been 750 mg per day for his weight, split into two doses)
Bicillin injection on day 21 and day 28 at the family doctor

On the 21st day, when they returned to their family doctor, Dr. XXXXXX XXXXXX, for the Bicillin injection, the doctor refused to administer it, citing a presumed allergy, though XXXXXX had no history of such an allergy. They then returned to the infectious disease doctor, who advised that no further treatment was necessary.

Believing the treatment was complete, the family returned home. Unfortunately, XXXXXX’s symptoms persisted, including fatigue and lack of appetite. A follow-up ELISA test returned negative, further misleading the family into thinking the infection was resolved.

Ongoing Symptoms and Additional Testing:
One month after completing treatment, XXXXXX developed a rash on his back, prompting his mother to research Lyme disease further. Realizing the possibility of incomplete treatment, she independently sought further testing. This time, both ELISA and Western Blot tests came back positive for Borrelia, confirming that the infection persisted despite the previous treatment.

Current Condition:
XXXXXX XXXXXX remains under medical observation, and his condition has raised concerns about the adequacy of the initial treatment he received. The incorrect antibiotic dosage during the initial treatment period, coupled with the refusal to administer the Bicillin injection, likely contributed to the persistence of the infection. His mother continues to seek appropriate care for him, hoping to achieve a full recovery.

Conclusion:
XXXXXX XXXXXX’s case underscores the challenges faced in diagnosing and treating Lyme disease in the Republic of Moldova. In this case, improper dosing and incomplete treatment, coupled with a lack of follow-up care, left the patient vulnerable to the persistence of Lyme disease. Despite early recognition of the infection, the inadequacies in treatment and medical oversight highlight the need for more standardized and effective protocols to manage Lyme disease, especially in children.

OUR FORMAL DEMANDS TO THE HEALTHCARE SYSTEM

1. Every laboratory must clearly disclose the manufacturer of the tests it offers and prominently indicate on the result form the strains included in the test (as guaranteed by the supplier), along with a detailed breakdown of the bands.

2. Every laboratory conducting tests for Borrelia (whether hospital-based or not) must state on the result form that a negative test result does not rule out the presence of the disease.

3. Any doctor referring a patient for Borrelia testing must inform the patient about all types of Borrelia found in Europe, as well as the different types of tests available, outlining their respective advantages and limitations. If necessary, the doctor should familiarize themselves thoroughly with the subject.

4. Any doctor whose patient presents with unexplained symptoms must refer them for infection testing. This necessitates that doctors in Europe immediately update their knowledge of the disease.

5. Any doctor in Europe referring a patient for Borrelia testing must first explain to the patient that the test results will depend primarily on the patient’s immune system and how it has been affected by the infection, rather than the test itself or whether the patient is infected. Patients should also be informed about ways to potentially improve the test’s effectiveness by boosting their immune response and breaking down Borrelia biofilms through scientifically proven methods.

6. Any doctor treating the infection must inform their patients about the possibility of biofilm formation, the persistence of the bacteria in collagen tissues, and the potential for the proposed therapy to fail to fully eradicate the infection. The doctor must also emphasize the possibility of false-negative test results after treatment, regardless of when the tests are performed.

7. Governments in Europe must promptly provide a statement and response regarding the "MOTION FOR A RESOLUTION on Lyme disease (Borreliosis)" – B8-0514/2018. This should include a detailed analysis of the proposal's content, the legal obligations of each country, and a position aligned with both European and national priorities. Government responses must be timely and transparent to inform the public about the actions taken and the stance of European countries.

8. Any individual in Europe with antibodies detected in their Western blot test (regardless of whether the result is formally indicated as negative) must have the right to purchase antibiotic products from pharmacies in their country with a prescription from a doctor in any country worldwide. Any denial of this right should be considered a violation of the individual's right to protect their life and health. Any claim that restricting access to medication for the world’s most widespread infectious disease (Borrelia) is for the public good should be viewed as manipulation and a deliberate act of harm to millions of individuals.

9. Any doctor in Europe who informs a patient that they do not have a Borrelia infection must be able to scientifically substantiate their conclusions by clearly explaining the presence of antibodies in the patient’s test results, supported by indisputable evidence. If the doctor fails to provide such an explanation, the patient should be exempt from paying the consultation fee.

10. Every neurologist in Europe must, by law, immediately cease commenting on the mental health of their patients and instead focus on potential infections.

11. Every psychiatrist must be required to refer patients for infection testing if they report symptoms such as fatigue, dizziness, poor concentration, blurred vision, chronic sleep disturbances, tinnitus, or pain.

12. Every psychiatrist must be legally obligated to refer patients for infection testing if they present with symptoms such as fatigue, dizziness, poor concentration, blurred vision, chronic sleep issues, tinnitus, or pain. Doctors in other specialties, except psychiatrists, must also be legally required to stop attributing such symptoms to psychological issues.

13. Before conducting in vitro procedures, every clinic in Europe offering these services must inquire about the presence of unexplained symptoms such as fatigue, general malaise, difficulty concentrating, or anxiety. If clients report such symptoms, the clinic must consider the possibility of infection before proceeding with the procedure.

14. Every dermatologist in Europe must refer patients for infection testing if they present with skin rashes.

15. Every cardiologist in Europe must refer patients for infection testing if they exhibit symptoms such as irregular heart rhythms or shortness of breath that cannot be attributed to a confirmed cardiac condition.

16. Governments and health authorities across Europe must immediately make public the established potential scale of infection, as outlined in the 2021 study "Global Seroprevalence and Sociodemographic Characteristics of Borrelia burgdorferi sensu lato in Human Populations: A Systematic Review and Meta-Analysis." This study provides critical data on the global spread of the infection, which should be made accessible to the public to raise awareness and support appropriate prevention and treatment measures.

OUR PUBLIC RECOMMENDATIONS FOR MORE ACCURATE TESTING AND DETAILED EXPLANATION OF AVAILABLE TESTS IN EUROPE:

https://lymecare.org/posts/preparing/

OUR PUBLIC APPEAL, AVAILABLE IN 8 LANGUAGES:

https://lymecare.org/posts/globalhealthcrisis/

Thank you for your time and attention on behalf of those still fighting for their lives, and the millions of others who need light and hope for salvation. Unfortunately, we have already witnessed deaths in just the past month. We urge you to start saving the lives of innocent people.

Published on: November 5, 2024 Updated on: December 1, 2024

Author: LymeCare Alliance

Preparing for Lyme Disease (Borrelia) Testing
Discover the most accurate Lyme disease testing options, including blood tests, biofilm breakdown, and Dark Field Microscopy. Learn how to interpret test results effectively for a reliable diagnosis of Borrelia and Lyme disease.
Why Millions Are Suffering in Silence: A Global Health Crisis
Lyme disease remains a silent pandemic affecting millions. With symptoms that mimic other conditions, misdiagnosis is common, leaving patients untreated. Spread awareness to help doctors recognize the complexities of this misunderstood disease.
Critical Role of the P41 Flagellin Band in Lyme Disease Testing: Western Blots, Diagnostics, and Modern Advancements
Discover how the p41 flagellin band plays a crucial role in Lyme disease testing, especially in Western blot diagnostics. Learn about modern advancements that enhance test accuracy, reduce cross-reactivity, and lead to more reliable diagnoses for better patient outcomes.
Health crisis ignored by EU governments for 6 years - millions suffer in silence
The LymeCare Alliance calls attention to a hidden health crisis impacting millions in Europe, as EU governments have ignored a 2018 resolution urging action on Borrelia, a bacterial infection affecting up to 25% of the population. Misdiagnosis and outdated testing protocols leave patients untreated and disabled, with healthcare systems failing to adopt accurate diagnostic methods. Unlike the U.S., where testing limitations for Lyme disease are disclosed, European patients are often misled, even when tests are positive. This open letter urges political leaders and the media to expose this neglect and drive urgent reform to prevent further suffering and loss of life across the continent.
Nearly 400 Years Needed to Reveal the Truth: Mental illness turns out to be Lyme disease
Uncover the truth behind Morgellons and its potential connection to Lyme disease, a stealthy epidemic linked to over 300 conditions affecting millions worldwide.
Symptoms of Lyme Disease: A Complete Guide to All Possible Signs and Indicators
Lyme Disease can present a wide variety of symptoms. This comprehensive guide covers all possible signs and indicators to help with accurate recognition and diagnosis.
DualDur: A Revolutionary Diagnostic Tool for Lyme Disease
DualDur test redefines Lyme disease diagnosis by directly detecting Borrelia in the blood. Offering precise results in both early and chronic stages, this innovative method surpasses traditional testing, ensuring accurate diagnoses and better treatment outcomes for Lyme disease patients.
LTT Test for Lyme Disease: Does It Really Work and Is It Reliable?
The Lymphocyte Transformation Test (LTT) for Lyme disease offers an alternative approach to diagnosing this complex infection. But does it live up to expectations? Explore the reliability, accuracy, and practical use of the LTT test to understand whether it’s the right diagnostic tool for Lyme disease.
Feeling Dizzy, Wobbly, or Off-Balance? Understanding and Addressing Walking Instability
Feeling dizzy, lightheaded, or unsteady while walking? These troubling symptoms can stem from inner ear issues, neurological conditions, cardiovascular problems, or even psychological factors. This in-depth guide unpacks the leading causes of dizziness and walking instability, offering evidence-based solutions and cutting-edge treatments. Take the first step toward a stable, confident life by understanding the science behind balance disorders.
Understanding Dry Eyes: Causes, Treatments, and Relief Solutions
Dry eyes, marked by irritation, grittiness, and visual discomfort, are a growing concern in our modern, technology-driven world. With causes ranging from screen use and environmental factors to underlying health conditions like Lyme disease or autoimmune diseases, understanding the root of the problem is essential for effective management. Explore this in-depth guide to uncover the leading causes of dry eyes, the latest treatments—including advanced therapies and natural remedies—and practical solutions for relief.

Previous article Symptoms of Lyme Disease: A Complete Guide to All Possible Signs and Indicators

Health crisis ignored by EU governments for 6 years - millions suffer in silence

An open letter to Europe's political leaders, media and organizations

Dear European Political Leaders,

Dear Members of the Media,

Dear Representatives of Esteemed Organizations,

REPORT ON THE PANDEMIC

Evidence of the Hidden Pandemic

An urgent motion for a resolution on Lyme disease has been submitted to the European Parliament, yet governments and the EU remain silent

Lyme disease can be transmitted from pregnant women to their babies

Possible Sexual Transmission of Lyme Disease

Doctors Are Unaware of the True Symptoms of Lyme Disease in Europe

How is it possible for so many people to suffer from a single bacterial infection without adequate diagnosis or treatment?

Patients with diseases like multiple sclerosis (MS) and fatal conditions such as ALS have had undiagnosed Lyme disease for many years

Even Scarier: Lyme Disease Tests Don’t Work, and Doctors Don’t Know It

Borrelia Biofilms: Another Overlooked Topic Among Mainstream Doctors

Pre-Test Preparation for Lyme Disease: Breaking Down Biofilms

The Failure of Doctors to Recognize Borrelia is Crippling and Killing People

Treatment: It’s Not What’s in the Textbooks, and Every Doctor Should Know This

And Now the Reality Becomes Even More Brutal

An Even More Frightening Truth

A Crime Against Humanity

DESCRIPTION OF PATIENT CLINICAL CASES

Clinical case: XXXXXX XXXXXX

Clinical case: XXXXXX XXXXXX

Clinical case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

Clinical Case: XXXXXX XXXXXX

OUR FORMAL DEMANDS TO THE HEALTHCARE SYSTEM

Related posts:

Comments on “An open letter to Europe's political leaders, media and organisations”

Author

Web site

What is the name of the bacteria that many of the readers of this site have? First name in lower case only (Anti-spam protection)

Your Comment